Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

'Fighting the invisible enemy – An update on Therapeutic HPV vaccine development'


Dr Karin HellnerDr Karin Hellner attended medical school in Germany and holds a medical PhD. Her postdoctoral research at Harvard Medical School focussed on the discovery of novel therapeutics for HPV associated cancers. She joined Oxford University 12 years ago as a clinical lecturer. After completing her clinical training in obstetrics & gynaecology, she was appointed as Senior Fellow in Women’s Health. She is an honorary consultant gynaecologist at OUH and leads the trust’s colposcopy department. Her research aims at utilizing the body’s immune system to fight persistent infections with HPV and precancers. She is the Chief-investigator for the first in-human trial of a therapeutic vaccine that was developed in Oxford.





Chair: Associate Professor James FitzGerald  

All members of the University and NHS clinical staff are welcome.

Please email Louise King if you would like to attend online.